垂体瘤的立体定向放射治疗进展  

Progress of Stereotactic Radiotherapy of Pituitary Adenomas

作　　者：马玉超[1] 肖建平[1] 

机构地区：[1]中国医学科学院,北京协和医学院肿瘤医院肿瘤研究所放射治疗科,北京100021

出　　处：《中国神经肿瘤杂志》2013年第4期242-247,共6页Chinese Journal of Neuro-Oncology

摘　　要：垂体瘤是常见的颅内肿瘤,分为功能性和无功能性两种。控制肿瘤体积及激素水平为其治疗的两大目标。立体定向放射治疗作为垂体瘤二线治疗方案,获得了良好的肿瘤控制率及激素缓解率,但仍不可避免地存在一些治疗后并发症,最主要的为放疗相关垂体功能减退。本文总结近几年关于立体定向放疗治疗垂体瘤的文献,将国内外学者的共识及争议点加以综述。Pituitary adenomas are common intracranial tumors, which are divided into two kinds-functional and non-functional. The main goal of the treatment is the control of the tumor volume and hormone level. Stereotactic radiotherapy, as a second-line therapy, has gained favorable tumor control and hormone release rate. However, complications after treatment are inevitable, of which the most important is radiotherapy-induced hypopituitarism. This review summarizes recently published papers about stereotactic radiotherapy of pituitary adenomas and presents the consensus and controversial points of researchers at home and abroad.

关 键 词：垂体瘤 立体定向放射治疗 垂体功能减退 

分 类 号：R739.41[医药卫生—肿瘤]